Junk Fees at JFK, LaGuardia and Newark Airports
Why are these airport vendors slyly charging consumers for “employee benefits”?
Growth Factor-9
April 2017: The Ninth Circuit Court of Appeals affirmed the district court’s dismissal of this lawsuit.
March 2015: The named plaintiff filed a Notice of Appeal regarding the decision to dismiss this action. (Engel v. Novex Biotech, LLC et al, Case No. 15-15492, 9th Cir.)
February 2015: A federal judge dismissed a false advertising class-action lawsuit against Novex Biotech, LLC and GNC Corp. The 2014 complaint alleged that the companies falsely advertised Growth Factor-9, an over-the-counter amino acid supplement, as “clinically tested” to provide a “682% mean increase in serum growth hormone levels” without adequate scientific evidence to support such claims. The judge dismissed the complaint because, among other things, the plaintiffs did not cite any scientific study that disproves the advertised claims. The lawsuit was dismissed with prejudice, meaning that the plaintiffs cannot refile the complaint. (Engel et al v. Novex Biotech LLC and GNC Corp., Case No. 14-cv-03457, N. D. CA.)
For more information about the advertising of supplements and TINA.org’s coverage of the issue, click here.
The Latest
FTC Takes TruHeight’s Growth Claims Down a Few Pegs
Supplement maker agrees to pay $750K to settle deceptive health claims lawsuit.
Extra: Overthink Less. Chew Good.
Every now and then you overthink.
FTC Cracks Down on Forever Living Following Years of Deception
Settlement comes after TINA.org exposed thousands of deceptive income claims.
What You Should Know about Home Projectors
TINA.org sheds light on confusing and misleading brightness claims.